Do you want to read an article? Please log in or register.
Risk of inflammation, retinal vasculitis and retinal occlusion-related events with brolucizumab: post-hoc review of HAWK and HARRIER
Macular DiseasesRetinal Diseases
COMMENTED
Related content
COMMENTED
Macular DiseasesFurther Publications
Clinical Characteristics and Outcomes of Eyes with Intraocular Inflammation after Brolucizumab: Post Hoc Analysis of HAWK and HARRIER
★ 2
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
Ophthalmol Retina
Singer M, Albini TA, Seres A, Baumal CR, Parikh S, Gale R, Kaiser PK, Lobach I, Feltgen N, Joshi MR, Ziemssen F, Bodaghi B
doi: 10.1016/j.oret.2021.05.003
Macular Diseases
HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration
Ophthalmology.
Dugel PU, Koh A, Ogura Y, Jaffe G, Schmidt-Erfurth U, Brown D, Gomes AV, Warburton J, Weichselberger A, Holz FG, HAWK and HARRIER Study Investigators
doi: 10.1016/j.ophtha.
Macular DiseasesRetinal DiseasesFurther Publications
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial
JAMA Ophthalmol
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL, Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group.
doi: 10.1001/jamaophthalmol.2021.4395
Uveitis
Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials
Ophthalmology.
Suhler EB, Thorne JE, Mittal M, Betts KA, Tari S, Camez A, Bao Y, Joshi A
doi: 10.1016/j.ophtha.2017.06.017.
Retinal Diseases
Vancomycin-associated hemorrhagic occlusive retinal vasculitis: a clinical-pathophysiological analysis
Am J Ophthalmol.
Todorich B, Faia LJ, Thanos A, Amin M, Folberg R, Wolfe JD, Todorich KM, Raphtis E, Ruby AJ, Williams GA, Hassan TS
doi: 10.1016/
RECOMMENDED
Retinal Diseases
Review of people with retinal vasculitis and positive QuantiFERON®-TB Gold test in an area nonendemic for tuberculosis
Int Ophthalmol.
Brunner DR, Zweifel SA, Barthelmes D, Meier F, Böni C
doi: 10.1007/s10792-017-0739-4.
Retinal Diseases
Retinal Nonperfusion in the Posterior Pole Is Associated With Increased Risk of Neovascularization in Central Retinal Vein Occlusion
Am J Ophthalmol.
Nicholson L, Vazquez-Alfageme C, Patrao NV, Triantafyllopolou I, Bainbridge JW, Hykin PG, Sivaprasad S
doi: 10.1016/j.ajo.2017.07.015.
Retinal Diseases
Vision-Related Functioning in Patients Undergoing Pneumatic Retinopexy vs Vitrectomy for Primary Rhegmatogenous Retinal Detachment: A Post Hoc Exploratory Analysis of the PIVOT Randomized Clinical Trial
JAMA Ophthalmol.
Muni RH, Francisconi CLM, Felfeli T, Mak MYK, Berger AR, Wong DT, Altomare F, Giavedoni LR, Kohly RP, Kertes PJ, Figueiredo N, Zuo F, Thorpe KE, Hillier RJ
doi: 10.1001/jamaophthalmol.2020.2007.
Ambient Air Pollution and the Risk of Central Retinal Artery Occlusion
Ophthalmology.
Cheng HC, Pan RH, Yeh HJ, Lai KR, Yen MY, Chan CL, Wang AG
doi: 10.1016/